Literature DB >> 6085200

Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12.

B H Robertson, D O Morgan, D M Moore.   

Abstract

The epitopes of six monoclonal antibodies generated against type A12 foot-and-mouth disease virus (FMDV) VP1 or its largest cyanogen bromide fragment (13 kd) were characterized. Five of these monoclonal antibodies neutralized viral infectivity. Solid-phase and competitive antigen binding assays using virion-derived antigens or a biosynthetic VP1 polypeptide identified two distinct neutralizing epitopes. One epitope was located between amino acid residues 145-168 of VP1 and the other between amino acids 169-179. The results indicate that antibodies reacting with two distinct areas of the VP1 polypeptide are capable of neutralizing FMD virus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6085200     DOI: 10.1016/0168-1702(84)90006-6

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  11 in total

1.  Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.

Authors:  J C Saiz; M J Gonzalez; M V Borca; F Sobrino; D M Moore
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells.

Authors:  M J Grubman; D O Morgan; J Kendall; B Baxt
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

3.  Characterization of monoclonal antibodies against a type SAT 2 foot-and-mouth disease virus.

Authors:  J R Crowther; C A Rowe; R Butcher
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

4.  Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins.

Authors:  J Chinsangaram; C Beard; P W Mason; M K Zellner; G Ward; M J Grubman
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 5.  An overview on ELISA techniques for FMD.

Authors:  Li-na Ma; Jie Zhang; Hao-tai Chen; Jian-hua Zhou; Yao-zhong Ding; Yong-sheng Liu
Journal:  Virol J       Date:  2011-09-04       Impact factor: 4.099

6.  Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus.

Authors:  B Baxt; V Vakharia; D M Moore; A J Franke; D O Morgan
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

7.  Induction of foot-and-mouth disease virus-specific cytotoxic T cell killing by vaccination.

Authors:  Jared R Patch; Lasse E Pedersen; Felix N Toka; Mauro Moraes; Marvin J Grubman; Morten Nielsen; Gregers Jungersen; Soren Buus; William T Golde
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

8.  Cross-reactive idiotopes among anti-foot and mouth disease virus neutralizing antibodies.

Authors:  M V Borca; A E Garmendia; B Baxt; D M Moore; S Srikumaran; D O Morgan
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

9.  Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs.

Authors:  S A Lewis; D O Morgan; M J Grubman
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

Review 10.  Protective immune response against foot-and-mouth disease.

Authors:  K C McCullough; F De Simone; E Brocchi; L Capucci; J R Crowther; U Kihm
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.